130 results
Page 2 of 7
425
rkoli0m87kra8 6345p2
2 Oct 23
Business combination disclosure
5:31pm
8-K
fynqobxpsd
2 Oct 23
Other Events
5:30pm
425
35d w69jbn
18 Sep 23
Business combination disclosure
5:27pm
8-K
c5wm jabkk
18 Sep 23
Other Events
5:27pm
425
EX-99.1
9k3uwc3k2xlykwlxpsd
6 Sep 23
Business combination disclosure
8:17am
8-K
EX-99.1
xpeqx3sp92h8xqza
6 Sep 23
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
8:13am
424B3
8lrcp385t oc7y
5 Sep 23
Prospectus supplement
6:02pm
425
EX-99.1
ldh6m
14 Aug 23
Business combination disclosure
8:06am
8-K
EX-99.1
cnm79u6k83yinr
14 Aug 23
VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
8:05am
S-4/A
EX-10.20
ooco im4t6nqzuy3s1
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4/A
c2expz4uaj fm5yb
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
425
lqclw
9 Jun 23
Business combination disclosure
4:31pm
425
dhwz7gf nf3f
17 May 23
Business combination disclosure
4:54pm
10-Q
e20vl725
15 May 23
Quarterly report
4:30pm
425
EX-99.1
6ult5mw1
15 May 23
Business combination disclosure
4:06pm
8-K
EX-99.1
draduv2xyt
15 May 23
VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm